HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
Clinical trial NCT01565200 · COMPLETED
Trial details
- NCT number
- NCT01565200
- Sponsor
- Jules Bordet Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2017-07-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.